Pregled bibliografske jedinice broj: 1270983
Successful Treatment of a Rare Cholesterol Homeostasis Disorder Due to CYP27A1 Gene Mutation with Chenodeoxycholic Acid Therapy
Successful Treatment of a Rare Cholesterol Homeostasis Disorder Due to CYP27A1 Gene Mutation with Chenodeoxycholic Acid Therapy // Biomedicines, 11 (2023), 5; 1430, 11 doi:10.3390/biomedicines11051430 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1270983 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Successful Treatment of a Rare Cholesterol
Homeostasis Disorder Due to CYP27A1 Gene Mutation
with Chenodeoxycholic Acid Therapy
Autori
Brlek, Petar ; Bulić, Luka ; Glavaš Weinberger, David ; Bošnjak, Jelena ; Pavlović, Tomislav ; Tomić, Svetlana ; Krivdić Dupan, Zdravka ; Borić, Igor ; Primorac, Dragan
Izvornik
Biomedicines (2227-9059) 11
(2023), 5;
1430, 11
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
ataxia ; cerebrotendinous xanthomatosis ; chenodeoxycholic acid ; cholestanol ; xanthoma ; next-generation sequencing
Sažetak
Cerebrotendinous xanthomatosis (CTX) is a genetic disorder of the cholesterol metabolic pathway, most often associated with variants in the CYP27A1 gene. The dysregulation of cholesterol metabolism results in the accumulation of metabolites such as cholestanol, which has a predilection for neuronal tissue and tendons. The condition is treatable with chenodeoxycholic acid (CDCA), which halts the production of these metabolites. We present two adult brothers, without diagnosis, suffering from ataxia, general muscle weakness and cognitive deficits. Both brothers suffered from early onset cataracts, watery stools and thoracic kyphoscoliosis. Magnetic resonance imaging revealed hyperintense alterations in the central nervous system and intratendinous xanthomas in the Achilles tendons. A biochemical analysis showed elevated levels of cholestanol, lathosterol and 7- dehydrocholesterol. Their family history was negative for neurological and metabolic disorders. Genetic testing revealed a pathogenic CYP27A1 variant (c.1184+1G>A) in both brothers, confirming the diagnosis. The patients were started on CDCA therapy and have shown significant improvement at their follow-up examinations. Early diagnosis and treatment initiation in CTX patients is of great importance, as the significant reversal of disease progression can be achieved. For this reason, clinical genetic testing is necessary when it comes to patients with an onset of cataracts, chronic diarrhea, and neurological symptoms in early childhood.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Osijek,
Klinički bolnički centar Zagreb,
Medicinski fakultet, Split,
Medicinski fakultet, Osijek,
Sveučilište u Splitu Sveučilišni odjel zdravstvenih studija,
Specijalna bolnica Sv. Katarina,
Fakultet za dentalnu medicinu i zdravstvo, Osijek
Profili:
Luka Bulić
(autor)
Jelena Bošnjak
(autor)
Zdravka Krivdić
(autor)
David Glavaš Weinberger
(autor)
Igor Borić
(autor)
Dragan Primorac
(autor)
Svetlana Tomić
(autor)
Petar Brlek
(autor)
Tomislav Pavlović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus